AF488 Anti-Human CD19 Antibody[4G7]

Introducing the AF488 Anti-Human CD19 Antibody [4G7], a highly advanced and meticulously engineered product designed to revolutionize the field of immunology. This antibody, developed with utmost precision, exhibits exceptional specificity and affinity towards the CD19 antigen found on human cells.

The AF488 Anti-Human CD19 Antibody [4G7] is a cutting-edge tool that enables researchers and scientists to delve deeper into the intricate mechanisms of the immune system. Its remarkable fluorescence properties, powered by the AF488 dye, facilitate accurate and reliable detection of CD19 expression in various experimental settings.

Crafted with the utmost care, this antibody undergoes rigorous quality control measures to ensure unparalleled performance and reproducibility. Its exceptional binding affinity to CD19 guarantees precise and reliable results, making it an indispensable asset for immunological research, diagnostic applications, and therapeutic development.

The AF488 Anti-Human CD19 Antibody [4G7] is meticulously manufactured using state-of-the-art techniques, ensuring batch-to-batch consistency and reliability. Its exceptional specificity towards the CD19 antigen minimizes the risk of cross-reactivity, allowing for precise and accurate analysis of CD19 expression in diverse biological samples.

This antibody's versatility extends beyond research applications, as it holds immense potential for clinical use. Its ability to specifically target CD19, a key marker in various hematological malignancies, opens doors for potential therapeutic interventions and personalized medicine approaches.

In summary, the AF488 Anti-Human CD19 Antibody [4G7] represents a groundbreaking advancement in immunological research and clinical applications. Its exceptional specificity, reliability, and versatility make it an indispensable tool for scientists, researchers, and clinicians alike, propelling the boundaries of knowledge and paving the way for innovative therapeutic strategies.